Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump administration looks at importing drugs to control prices

The Trump administration is taking a wide approach in its efforts to lower drug prices—even considering importing drugs from abroad. 

Thumbnail

OMB review underway to unfreeze $10B in ACA payments

The Office of Management and Budget (OMB) is reviewing a rule to unlock roughly $10 billion in payments for Affordable Care Act (ACA) insurance providers.

Thumbnail

Medicare competitive bidding process hurts patients

The Medicare bidding process is hurting patients, according to a new study from the Pacific Research Institute.

Thumbnail

How will radiology providers be reimbursed for investing in AI?

Countless studies have explored the colossal impact artificial intelligence (AI) will have—and, in many ways, is already having—on radiology. But who is ultimately going to pay for it?

Thumbnail

Amid revenue growth, UnitedHealth considers acquiring $2B Tenet subsidiary

UnitedHealth Group is exploring an acquisition of Tenet Healthcare’s healthcare management subsidiary, Conifer Health Solutions, according to the The Wall Street Journal.

CMS opens comment period for Kentucky Medicaid work requirements

After a federal judge blocked work requirements for Medicaid beneficiaries in Kentucky, CMS has opened a pathway for the policy.

Facing pressure from Trump, another drug manufacturer drops price hikes

Novartis, one of the world’s biggest pharmaceutical companies, has paused any price hikes on its drugs for the remainder of 2018.

FDA unveils plan to lower prices, boost competition among drug-makers

The FDA unveiled a new plan to enable market competition for biologics and biosimilars Wednesday, July 18, as part of a larger shift to lower drug prices across the healthcare system.